Safety of intramuscular tixagevimab-cilgavimab (Evusheld®) administration in patients at risk of iatrogenic haematoma due to haematological disorders.
Saved in:
| Title: | Safety of intramuscular tixagevimab-cilgavimab (Evusheld®) administration in patients at risk of iatrogenic haematoma due to haematological disorders. |
|---|---|
| Authors: | Malherbe JAJ; Department of Haematology, Fiona Stanley Hospital, Murdoch WA, Australia.; School of Biomedical Sciences, University of Western Australia, Crawley WA, Australia., Misko J; Department of Pharmacy, Fiona Stanley Hospital, Murdoch WA, Australia., Jayawardena NK; Department of Haematology, Fiona Stanley Hospital, Murdoch WA, Australia., Rawlins MDM; Department of Pharmacy, Fiona Stanley Hospital, Murdoch WA, Australia., Manning L; Department of Infectious Diseases, Fiona Stanley Hospital, Murdoch WA, Australia.; School of Medicine, University of Western Australia, Crawley WA, Australia., Purtill D; Department of Haematology, Fiona Stanley Hospital, Murdoch WA, Australia.; PathWest Laboratory Medicine WA, Murdoch, WA, Australia. |
| Source: | Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners [J Oncol Pharm Pract] 2026 Jan; Vol. 32 (1), pp. 32-37. Date of Electronic Publication: 2024 Sep 17. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1477-092X |
|---|---|
| DOI: | 10.1177/10781552241284944 |
